News archives

Home > News archives > Closing of the Series C funding to advance pipeline of novel GPCR antibodies

Closing of the Series C funding to advance pipeline of novel GPCR antibodies

Aug 24,2021 -- Updated 16:32 +0900 (GMT)

NBHL has closed the Series C funding to advance pipeline of novel GPCR antibodies.

Click here for detail.